Joel Barker

A well-known drug is being tested to attack Alzheimer’s symptoms

Joel Barker joins Jim Blasingame to report on an existing drug that’s used for other issues, which is being tested to see if it’s properties might reduce the plaque on the brain that causes Alzheimer’s disease.

More interviews with Joel Barker »See all

Joel Barker joins Jim Blasingame to report on how probiotics and antibiotics are being combined to improve effectiveness, plus turning graphene into smart robots at the atomic level to be used as scouts and delivery.
Joel Barker joins Jim Blasingame to report on the news that China has successfully manipulated human genes in a set of twins, and some of the many benefits and ethical firewalls going forward.
Joel Barker joins Jim Blasingame to report on recent breakthroughs with turning plastic bottles, etc. into a kind of aerogel that becomes a multi-purpose insulator, thus turning a menacing waste into a useful product.
Joel Barker joins Jim Blasingame to report on how probiotics and antibiotics are being combined to improve effectiveness, plus turning graphene into smart robots at the atomic level to be used as scouts and delivery.
Joel Barker joins Jim Blasingame to report on the news that China has successfully manipulated human genes in a set of twins, and some of the many benefits and ethical firewalls going forward.